Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days for Report: Lung Cancer Mutation Panel-3

The report for the Lung Cancer Mutation Panel-3 test can be obtained within 7-10 business days from the date of sample collection.

What are the prerequisites for the test Lung Cancer Mutation Panel- 3

  • Patient must have a confirmed diagnosis of lung cancer
  • Patient must be willing to undergo genetic testing
  • Adequate tissue sample for testing
  • Physician's order for the test

What are the measure values for the test Lung Cancer Mutation Panel- 3

Gene Mutation Measure Value
EGFR L858R Positive
TP53 R273H Positive
KRAS G12D Negative

What does this test Lung Cancer Mutation Panel- 3 identify?

Lung Cancer Mutation Panel- 3

The Lung Cancer Mutation Panel- 3 is a genetic test that identifies specific mutations in genes that are commonly associated with lung cancer. This panel helps in determining the genetic profile of the tumor and guiding treatment decisions.

The test identifies mutations in genes such as EGFR, ALK, ROS1, BRAF, and others. These mutations can help in predicting the response to targeted therapies and immunotherapies. The results of this panel can also provide information on prognosis and potential resistance to certain treatments.

Overall, the Lung Cancer Mutation Panel- 3 is a valuable tool in personalized medicine for lung cancer patients, helping to tailor treatment plans based on the individual genetic makeup of the tumor.

Why is this test Lung Cancer Mutation Panel- 3 taken?

Reasons for taking Lung Cancer Mutation Panel-3 Test

  • Identification of specific mutations: The Lung Cancer Mutation Panel-3 test is taken to identify specific mutations in genes that are associated with lung cancer. These mutations can help in determining the appropriate treatment options and prognosis for patients.
  • Precision medicine: By identifying mutations through this panel test, healthcare providers can personalize treatment plans for patients with lung cancer. This approach, known as precision medicine, aims to target the specific genetic alterations driving the cancer.
  • Predicting response to targeted therapies: The results of the Lung Cancer Mutation Panel-3 test can help predict how a patient's cancer may respond to certain targeted therapies. This information can guide treatment decisions and improve outcomes.
  • Monitoring disease progression: Patients with lung cancer may undergo the Lung Cancer Mutation Panel-3 test at multiple points in their treatment journey to monitor disease progression and detect any new mutations that may have emerged.

Popular FAQs on Test

The Lung Cancer Mutation Panel- 3 test is a genetic test that analyzes specific genetic mutations associated with lung cancer. It helps identify mutations in genes that can impact treatment decisions and prognosis for patients with lung cancer.
Patients with lung cancer, especially non-small cell lung cancer, may benefit from the Lung Cancer Mutation Panel- 3 test to determine if they have specific mutations that could impact their treatment options.
The test is usually performed on a tissue sample obtained through a biopsy or surgery. The sample is sent to a laboratory where the genetic material is analyzed for specific mutations using advanced molecular techniques.
The Lung Cancer Mutation Panel- 3 test detects mutations in genes such as EGFR, ALK, ROS1, BRAF, and others that are known to play a role in the development and progression of lung cancer.
The turnaround time for the test results can vary depending on the laboratory performing the analysis. It typically takes 1-2 weeks to receive the results.

Customer Google Rating